B Lynne Parshall sold $274K of CYTK stock

B Lynne Parshall, Dir of Cytokinetics Inc (CYTK), sold 5,000 shares of CYTK stock worth $274K, per an SEC Form 4 filed Nov 12, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 9, 2026, 3 days before it was made public.

CYTK has moved +6.1% since the trade date, from $55.14 to $58.53 (Nov 11, 2026 close).